File(s) not publicly available
The myth of the biotech revolution
journal contributionposted on 2023-06-08, 00:27 authored by Paul NightingalePaul Nightingale, Paul Martin
The existence of a medicinal biotech revolution has been widely accepted and promoted by academics, consultants, industry and government. This has generated expectations about significant improvements in the drug discovery process, healthcare and economic development that influence a considerable amount of previous termpolicynext term-making. Here we present empirical evidence, from a variety of indicators, that shows that a range of outputs have failed to keep pace with increased previous termresearchnext term and development spending. Rather than producing revolutionary changes, medicinal biotechnology is following a well-established pattern of slow and incremental technology diffusion. Consequently, many expectations are wildly optimistic and over-estimate the speed and extent of the impact of biotechnology, suggesting that the assumptions underpinning much contemporary policymaking need to be rethought.
JournalTrends in Biotechnology
Department affiliated with
- SPRU - Science Policy Research Unit Publications
Full text available